Effect of bivalirudin on aortic valve intervention outcomes study: a two-centre registry study comparing bivalirudin and unfractionated heparin in balloon aortic valvuloplasty

Annapoorna Kini1, MD; Jennifer Yu1,2, MBBS; Mauricio G. Cohen3, MD; Roxana Mehran1, MD; Usman Baber1, MD; Samantha Sartori1, PhD; Georgios J. Vlachojannis1, MD; Jason C. Kovacic1, MD; Robert Pyo1, MD; Brian O’Neill3, MD; Vikas Singh3, MD; Evan Jacobs3, MD; Shyam Poludasu1, MD; Pedro Moreno1, MD; Michael C. Kim1, MD; Prakash Krishnan1, MD; Samin K. Sharma1, MD; George D. Dangas1*, MD, PhD

1. Mount Sinai Medical Center, New York, NY, USA; 2. Prince of Wales Clinical School, University of New South Wales, NSW, Australia; 3. University of Miami Miller School of Medicine, Miami, FL, USA

Aims: We sought to assess if bivalirudin use during balloon aortic valvuloplasty (BAV) would affect clinical outcomes compared with heparin.

Sign in to read and download the full article

Login Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

anticoagulantsballoon aortic valvuloplastybivalirudinbleeding

Share on Facebook Share on Twitter Share on Linkedin

Read next article

Functional coronary stenosis severity assessed from the mean pressure gradient-velocity relationship obtained by contrast medium-induced submaximal hyperaemia